Abstract
Hepatocellular carcinoma is the outcome of ongoing cycles of cell death and regeneration in chronic liver disease. In this issue of Cancer Cell, Nikolaou et al. show that the deubiquitinating enzyme CYLD is critical for controlling the balance between hepatocyte loss, regeneration, and malignant progression.
Original language | English |
---|---|
Pages (from-to) | 711-712 |
Number of pages | 2 |
Journal | Cancer Cell |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - Jun 12 2012 |